In complicated UTIs, cefepime-taniborbactam increased treatment success vs. meropenem at 19 to 23 d
{{output}}
Wagenlehner FM, Gasink LB, McGovern PC, et al; CERTAIN-1 Study Team. Cefepime-taniborbactam in complicated urinary tract infection. N Engl J Med. 2024;390:611-622. 38354140.
